Dr. Varinder Kaur, MD

Dr. Kaur practices at Emily Couric Clinical Cancer Center in Charlottesville, Virginia.

Dr. Kaur's NPI, 1811128846, was assigned on August 7, 2009. Dr. Kaur graduated from Government Medical College Chandigrah in 2004. Dr. Kaur holds Virginia license 0101260923.

Dr. Kaur's primary practice is Emily Couric Clinical Cancer Center, at 1240 Lee St,, Charlottesville, VA 22903. The practice phone is (434) 243-4704.

Dr. Kaur's primary practice is Emily Couric Clinical Cancer Center in Charlottesville, Virginia. Dr. Kaur is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Kaur to 2 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Kaur's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaur practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Kaur's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kaur is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kaur's licenses on file in 2 states: Virginia and Arkansas.

Dmand AI lists chronic anemia and colorectal cancer among the conditions Dr. Kaur treats.

CMS data shows 710 Medicare services from Dr. Kaur across 8 procedure codes in 2024, for 209 Medicare patients. Medicare paid $64,818 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 209 Medicare patients who saw Dr. Kaur in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 63% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaur's median patient age at 67, with 36% women.

In 2024, Dr. Kaur wrote 340 Medicare Part D claims for 76 patients. 79% of them were for generic drugs. CMS names the drug for 232 of them, across 9 drugs with 11 or more claims each, at $329,255 in total drug cost. In 2023, CMS named 145 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Kaur for performance year 2024, reported as part of a group. Dr. Kaur accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaur as offering telehealth.

Dmand AI links 77 papers to Dr. Kaur, published from 2014 to 2025. 2016 was the busiest year, with 9. The most frequent topics are Antioxidants, Plant Extracts and Antineoplastic Agents, Phytogenic. Dr. Kaur has published most often in J Oncol Pharm Pract. Dr. Kaur's most frequent co-authors are Manish Kumar, Daisy V. Alapat, MD and Peter D. Emanuel, MD.

Dmand AI links Dr. Kaur to 5 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell and Hypopharyngeal Neoplasms. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 10 general payments to Dr. Kaur from 4 drug and device companies from 2016 to 2022. Travel and lodging make up the largest share, 82% of the total. Merck Sharp & Dohme Corporation paid the most, $1,303.

Dmand AI lists 2 awards for Dr. Kaur, most recently Excellence in Clinical Care in 2019. Dr. Kaur serves on American Board of Internal Medicine Medical Oncology Item Writing Task Force, American Society of Clinical Oncology Self Evaluation Program (ASCO-SEP) Medical Oncology Self-Evaluation Program and ACP Virginia Chapter Governor's Advisory Council.

Dr. Kaur graduated from Government Medical College Chandigrah in 2004. Dr. Kaur is a member of AACR, ACP, AMA, ASCO and ASH.

Dr. Kaur is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.